The first clinical trials are already beginning, but widespread vaccination is still far away.
About 20 vaccines for the new type of COVID-19 coronavirus are being developed worldwide. Several countries are searching for a solution. The first clinical trials are already beginning, but widespread vaccination is still far away. The World Health Organization (WHO) stated this.
According to The Wall Street Journal, more than 20 thousand people agreed to participate in the search for a vaccine against the new coronavirus, along with British scientists from the hVIVO laboratory.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).